SCHEMBL12735455

SCHEMBL12735455

COc1ccc(Cc2nc3c(Cc4ccccc4)[nH]c(-c4ccc(OC)cc4)cn-3c2=O)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 8/20 0.43
▸ SMN1; SMN2 Q16637 4/20 0.43
▸ KMT2A Q03164 4/20 0.43
▸ MEN1 O00255 3/20 0.43
▸ ADORA3 P0DMS8 3/20 0.42
▸ KDM4E B2RXH2 7/20 0.42
▸ HPGD P15428 6/20 0.42
▸ HSD17B10 Q99714 3/20 0.42
▸ TP53 P04637 2/20 0.42
▸ APAF1 O14727 1/20 0.42
▸ HTT P42858 3/20 0.42
▸ LMNA P02545 1/20 0.42
▸ RAB9A P51151 2/20 0.41
▸ GAA P10253 2/20 0.41
▸ NPC1 O15118 1/20 0.41
▸ NPSR1 Q6W5P4 1/20 0.41
▸ PSD A5PKW4 2/20 0.41
▸ LTA4H P09960 1/20 0.41
▸ TDP1 Q9NUW8 1/20 0.40
▸ MLNR O43193 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10012889 0.99 KDM4E (0.43) ALDH1A1SMN1; SMN2KMT2AMEN1ADORA3
SCHEMBL4547065 0.98 ALDH1A1 (0.45) ALDH1A1SMN1; SMN2KMT2AMEN1ADORA3
SCHEMBL13484442 0.96 ALDH1A1 (0.42) ALDH1A1SMN1; SMN2KMT2AMEN1ADORA3
SCHEMBL12735454 0.95 MTOR (0.40) ALDH1A1SMN1; SMN2KMT2AMEN1ADORA3
SCHEMBL10196895 0.95 MTOR (0.40) ALDH1A1SMN1; SMN2KMT2AMEN1ADORA3
SCHEMBL29886558 0.94 ADORA3 (0.40) ALDH1A1SMN1; SMN2KMT2AMEN1ADORA3
SCHEMBL19810194 0.91 ALDH1A1 (0.39) ALDH1A1SMN1; SMN2KMT2AMEN1ADORA3
SCHEMBL20841724 0.90 ALDH1A1 (0.36) ALDH1A1SMN1; SMN2KMT2AMEN1ADORA3
SCHEMBL25760304 0.90 KDM4E (0.44) ALDH1A1SMN1; SMN2KMT2AMEN1ADORA3
SCHEMBL19206667 0.89 LTB4R (0.39) ALDH1A1ADORA3KDM4EHPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160362388-A1 CHEMILUMINESCENT METHODS AND REAGENTS FOR ANALYTE DETECTION WANG TIANXIN (US) 2016-12-15 — — US disclosed
US-9399657-B2 Chemiluminescent methods and reagents for analyte detection WANG TIANXIN (US) 2016-07-26 — — US disclosed
US-20110097753-A1 Chemiluminescent methods and reagents for analyte detection WANG TIANXIN 2011-04-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160362388-A1 CHEMILUMINESCENT METHODS AND REAGENTS FOR ANALYTE DETECTION UCHL1, LCT, SPR ALDH1A1 148/4885SMN1; SMN2 4735/4885KMT2A 2295/4885
US-20110097753-A1 Chemiluminescent methods and reagents for analyte detection UCHL1, LCT, SPR ALDH1A1 148/4885SMN1; SMN2 4735/4885KMT2A 2295/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback